Skip to content

Exelixis EXEL Return on assets

Return on assets at other companies

Eli Lilly logo
Eli LillyLLY
24.5%+10.1pp
Pfizer logo
PfizerPFE
4.6%
Summit Therapeutics logo
Summit TherapeuticsSMMT
-233.8%-558pp
Incyte logo
IncyteINCY
21.9%+21.5pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-10.4%-2.8pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-64.8%-9.5pp

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Calculated from Exelixis’s reported figures.

Based on trailing twelve months.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's return on assets?
Exelixis (EXEL) reported return on assets of 30.7% in Q1 2026.
How has Exelixis's return on assets changed year-over-year?
Exelixis's return on assets increased by 34.5% year-over-year, from 22.8% to 30.7%.
What is the long-term trend for Exelixis's return on assets?
Over 4 years (2020 to 2025), Exelixis's return on assets has grown at a 48.5% compound annual growth rate (CAGR), from 5.6% to 27%.
What does return on assets mean?
How much profit the company squeezes out of everything it owns.
How do you interpret return on assets?
Higher means more productive assets. Unlike ROE, it is unaffected by leverage, so a wide ROE-minus-ROA gap flags a heavily levered balance sheet.
How does return on assets compare across companies?
Best compared within an industry — asset intensity varies enormously across sectors. Not meaningful for banks, whose assets are largely financial.